• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

US Oncology Clinical Development Attends 'Partnerships With CROs'

Posted on: Monday, 13 April 2009, 09:58 CDT

HOUSTON, April 13 /PRNewswire/ -- US Oncology Clinical Development (USOCD), a full service contract research organization (CRO) will attend the 18th annual conference, Partnerships with CROs, scheduled for April 28-30 in Orlando, Fla. During the course of this meeting, USOCD will meet with key clinical trials contacts from the biotechnology and pharmaceutical industry to discuss how USOCD can help them succeed throughout the clinical trial management process.

US Oncology Clinical Development has exclusively managed oncology clinical trials for the last 10 years. Between a network of world renowned oncologists and its staff of experienced clinical trials experts, USOCD is uniquely poised to ensure the right subjects are enrolled within the designated timeline and budget. USOCD is equipped to provide its customers with oncology-specific clinical trials expertise, some of the most experienced oncology research sites in the country, medical monitors, and entire teams to do everything from designing and managing a trial to producing the final report.

About US Oncology Clinical Development

US Oncology Clinical Development is a full service CRO providing high quality, cost efficient, customized research and data management to clients across the industry. To learn more about USOCD services, please visit our Web site at http://www.usoncology.com, select Our Solutions, List of Services, US Oncology Clinical Development or contact Matt Wagener at matthew.wagener@usoncology.com.

About US Oncology

US Oncology, Inc., headquartered in the Houston area, works closely with physicians, payers, biotechnology, pharmaceutical and medical equipment manufacturers, to identify and deliver innovative services that enhance patient access to advanced cancer care. US Oncology supports one of the nation's foremost cancer treatment and research networks, accelerating the availability and use of evidence-based medicine and shared best practices.

US Oncology uses its expertise to support every aspect of the cancer care delivery system -- from drug development to distribution and outcomes measurement -- enabling the company to help increase the efficiency and safety of cancer care. As of the company's last quarterly earnings report, US Oncology is affiliated with 1,211 physicians operating in 456 locations, including 94 radiation oncology facilities in 39 states. For more information, visit the company's Web site, http://www.usoncology.com.

SOURCE US Oncology, Inc.

Source: PR Newswire

More News in this Category